Cardiovascular status in endogenous cortisol excess: the prospective CV-CORT-EX study
European Journal of Endocrinology · 2024
DOI: 10.1093/ejendo/lvae145 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Caroline Morbach und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center Würzburg, 97078 Würzburg, Germany. Hauptthemen laut MEDLINE: Cushing Syndrome, Hydrocortisone, Cardiovascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: German Ministry of Research and Education, Comprehensive Heart Failure Centre Würzburg, German Research Foundation.
Abstract (Originalsprache)
Objective
Cushing's syndrome (CS) results in increased cardiovascular (CV) morbidity and mortality. Subtype-specific differences and possible reversibility after biochemical cure are not well investigated.
Design
Prospective cohort study evaluating the CV status in different forms of endogenous cortisol excess.
Methods
Patients with overt CS (n = 40, 47 ± 13 years, 75% women; 18 pituitary, 13 adrenal, and 9 ectopic), biochemically cured CS (n = 56, 53 ± 12 years, 79% women; 30 pituitary, 21 adrenal, and 5 ectopic), and adrenal incidentalomas with mild autonomous cortisol secretion (MACS) (n = 18, 62 ± 11 years, 56% women) underwent comprehensive biochemical, metabolic, and CV assessment. Results were compared with a representative sample of the general population of Würzburg (n = 4965, 55 ± 12 years, 52% women).
Results
Overt CS was associated with left ventricular (LV) remodeling along with hypertrophy and impaired longitudinal systolic/diastolic function at echocardiography. In 20 CS patients followed for a median of 8 (quartiles: 6, 11) months after biochemical remission, hypertension, and hyperglycemia were better controlled, while cardiac alterations only partially improved. Patients with previous CS (median time of biochemical remission: 95 [36, 201] months) had worse diastolic function than the general population (LV relaxation velocity e′ 0.08 [0.07, 0.10] ms−1 vs 0.10 [0.08, 0.12] ms−1, P < .001). In MACS, cardiac remodeling was even more pronounced than in individuals with metabolic syndrome.
Conclusions
In patients with overt CS, cured CS, and MACS, we found a sizable and significant deviation from the general population mean regarding cardiac structure and function. Even mild cortisol excess is associated with glucocorticoid-induced cardiac alterations, which appear to persist despite long-term biochemical remission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center Würzburg, 97078 Würzburg, Germany.
- Department of Internal Medicine I, Division of Cardiology, University Hospital Würzburg, 97080 Würzburg, Germany.
- Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, 97080 Würzburg, Germany.
- Department of Internal Medicine IV, University Hospital Munich, Ludwig Maximilians-Universität München, 80336 München, Germany.
- Clinical Trial Center, University Hospital Würzburg, 97080 Würzburg, Germany.
- Institute for Clinical Epidemiology and Biometry, University of Würzburg, 97080 Würzburg, Germany.
ORCID-Profile: Caroline Morbach, Mario Detomas, Floran Sahiti, Stefan Frantz, Martin Fassnacht, Stefan Störk, Timo Deutschbein
Förderung
- German Ministry of Research and Education
- Comprehensive Heart Failure Centre Würzburg
- German Research Foundation
- Clinician Scientist Programme on Rare Important Syndromes in Endocrinology
- Else Kröner-Fresenius-Stiftung & Eva Luise und Horst Köhler Stiftung
- Interdisciplinary Center for Clinical Research
Zitieren
APA
Morbach, C., Detomas, M., Sahiti, F., Hoffmann, K., Kroiss, M., Gelbrich, G., Frantz, S., Hahner, S., Heuschmann, P. U., Fassnacht, M., Störk, S., & Deutschbein, T. (2024). Cardiovascular status in endogenous cortisol excess: the prospective CV-CORT-EX study. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae145
Vancouver
Morbach C, Detomas M, Sahiti F, Hoffmann K, Kroiss M, Gelbrich G, et al. Cardiovascular status in endogenous cortisol excess: the prospective CV-CORT-EX study. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae145
BibTeX
@article{Morbach2024,
author = {Morbach, Caroline and Detomas, Mario and Sahiti, Floran and Hoffmann, Kristina and Kroiss, Matthias and Gelbrich, Götz and Frantz, Stefan and Hahner, Stefanie and Heuschmann, Peter Ulrich and Fassnacht, Martin and Störk, Stefan and Deutschbein, Timo},
title = {Cardiovascular status in endogenous cortisol excess: the prospective CV-CORT-EX study},
journal = {European Journal of Endocrinology},
year = {2024},
doi = {10.1093/ejendo/lvae145}
}
EUVIMED